GridAI Technologies (GRDX) vs Incannex Healthcare (IXHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
GridAI Technologies (GRDX) has outperformed Incannex Healthcare (IXHL) over the past year, gaining 6.7% versus a loss of 75.4%. Incannex Healthcare is the larger company by market cap ($38.9 million vs $35.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRDX | IXHL |
|---|---|---|
| Share price | $4.97 | $3.10 |
| Market cap | $35.44M | $38.89M |
| 1-day change | +3.54% | -3.13% |
| YTD return | +6.65% | -71.14% |
| 1-year return | +6.65% | -75.40% |
| 5-year return | -99.99% | — |
| EPS (TTM) | $-5.65 | $-1.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.93 | $14.91 |
| 52-week low | $1.87 | $2.49 |
| Distance from 52-week high | -28.27% | -79.21% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +502.58% |
| Average volume | 104.68K | 93.98K |
| Shares outstanding | 7.13M | 12.54M |
| Employees | — | 12 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GRDX has outperformed IXHL by 82.0 percentage points over the past year.
About GridAI Technologies
GRDX stock →GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency.
Health Care · Biotechnology: Pharmaceutical Preparations
About Incannex Healthcare
IXHL stock →Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
GRDX vs IXHL FAQ
Which is bigger, GridAI Technologies or Incannex Healthcare?
Incannex Healthcare (IXHL) is larger, with a market capitalization of $38.89M compared with $35.44M for GridAI Technologies (GRDX).
Which stock has performed better over the past year, GRDX or IXHL?
GRDX returned +6.65% over the past 12 months, compared with -75.40% for IXHL (price return, excluding dividends). Past performance does not predict future results.
Are GridAI Technologies and Incannex Healthcare in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.